Log In
BCIQ
Print this Print this
 

rhFIB

  Manage Alerts
Collapse Summary General Information
Company Pharming Group N.V.
DescriptionRecombinant human fibrinogen
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationBleeding
Indication DetailsTreat bleeding in fibrinogen deficient patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today